Ironwood Pharmaceuticals (IRWD) Net Margin (2010 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Net Margin of 38.28% for Q1 2026, up 111.18% sequentially from 342.54% in Q4 2025, and up 12915.0% YoY from N/an in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Net Margin (2010 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Net Margin for 17 years, with the latest figure at 38.28% in Q1 2026.
- Quarterly Net Margin rose 12915.0% year-over-year to 38.28% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 16.31% (down 5416.0% YoY) and the FY2025 annual result came in at 46.3%, down 8996.0% from the prior year.
- Net Margin advanced to 38.28% in Q1 2026 per IRWD's latest filing, from 342.54% in the prior quarter.
- Over five years, Net Margin peaked at 170.96% in Q4 2024 and troughed at 1014.62% in Q2 2023.
- A 5-year average of 59.18% and a median of 27.69% in 2025 frame the typical range for Net Margin.
- The sharpest annual moves came in 2023 and 2024: Net Margin plunged 105276 bps in 2023, then surged 101371 bps in 2024.
- Over 5 years, Net Margin stood at 118.02% in 2022, then tumbled by 205 bps to 123.77% in 2023, then surged by 238 bps to 170.96% in 2024, then slumped by 300 bps to 342.54% in 2025, then jumped by 111 bps to 38.28% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 38.28%, 342.54%, and 32.84% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ironwood Pharmaceuticals | 688.03 Mn | 608.91 Mn | - | 45.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.37% |
| Mar 31, 2026 | 38.28% |
| Dec 31, 2025 | -342.54% |
| Sep 30, 2025 | 32.84% |
| Jun 30, 2025 | 27.69% |
| Mar 31, 2025 | -90.87% |
| Dec 31, 2024 | 170.96% |
| Sep 30, 2024 | 4.01% |
| Jun 30, 2024 | -0.91% |
| Mar 31, 2024 | -5.53% |
| Dec 31, 2023 | -123.77% |
| Sep 30, 2023 | 12.25% |
| Jun 30, 2023 | -1,014.62% |
| Mar 31, 2023 | 43.93% |
| Dec 31, 2022 | 118.02% |
| Sep 30, 2022 | 46.32% |
| Jun 30, 2022 | 38.14% |
| Mar 31, 2022 | 39.78% |
| Dec 31, 2021 | 35.33% |
| Sep 30, 2021 | 53.83% |